Axonal protective effects of the myelin-associated glycoprotein. [electronic resource]
- The Journal of neuroscience : the official journal of the Society for Neuroscience Jan 2009
- 630-7 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1529-2401
10.1523/JNEUROSCI.5204-08.2009 doi
Acrylamide--toxicity Action Potentials--genetics Age Factors Animals Animals, Newborn Cells, Cultured Cricetinae Cricetulus Disease Models, Animal GPI-Linked Proteins Ganglia, Spinal In Vitro Techniques Mice Mice, Inbred C57BL Mice, Knockout Motor Activity--drug effects Mutagenesis, Site-Directed--methods Myelin Proteins--deficiency Myelin-Associated Glycoprotein--deficiency Nerve Degeneration--etiology Nerve Fibers, Myelinated--metabolism Neural Conduction--genetics Neurofilament Proteins--metabolism Neuroprotective Agents--therapeutic use Nogo Receptor 1 Phosphoinositide Phospholipase C--toxicity Rats Receptors, Cell Surface--deficiency Spinal Cord Injuries--complications Time Factors Tubulin--metabolism Tubulin Modulators--therapeutic use Vincristine--therapeutic use